HELX vs. PSCH

Last updated Jun 5, 2026

HELX (Franklin Genomic Advancements ETF) and PSCH (Invesco S&P SmallCap Health Care ETF) are both Health & Biotech Equities funds. HELX is actively managed, while PSCH is passively managed. Over the past 5 years, HELX returned -3.93%/yr vs -5.22%/yr for PSCH. A 0.73 correlation means they provide meaningful diversification when combined. HELX charges 0.50%/yr vs 0.29%/yr for PSCH.

Performance

HELX vs. PSCH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Genomic Advancements ETF (HELX) and Invesco S&P SmallCap Health Care ETF (PSCH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HELX achieves a -1.55% return, which is significantly lower than PSCH's 4.52% return.

HELX

• 1D: 3.11%
• 1M: 5.81%
• YTD: -1.55%
• 6M: -4.90%
• 1Y: 33.84%
• 3Y*: 5.75%
• 5Y*: -3.93%
• 10Y*: —

PSCH

• 1D: 2.68%
• 1M: 2.04%
• YTD: 4.52%
• 6M: 0.76%
• 1Y: 13.07%
• 3Y*: 1.76%
• 5Y*: -5.22%
• 10Y*: 6.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HELX vs. PSCH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
HELX Franklin Genomic Advancements ETF	-1.55%	26.34%	-5.32%	1.14%	-37.89%	9.80%	85.05%
PSCH Invesco S&P SmallCap Health Care ETF	4.52%	-0.49%	3.77%	-2.71%	-25.15%	5.75%	38.50%

Correlation

The correlation between HELX and PSCH is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.77
Correlation (3Y) Calculated over the trailing 3-year period	0.79
Correlation (5Y) Calculated over the trailing 5-year period	0.78
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020	0.73

The correlation between HELX and PSCH has been stable across timeframes, ranging from 0.73 to 0.79 - a consistent structural relationship.

HELX vs. PSCH - Sectors Allocation Comparison

Sectors	HELX	PSCH
Healthcare	96.5%	97.3%
Basic Materials	2.7%	-
Technology	0.9%	1.7%
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	1.1%
Industrials	-	0.7%
Real Estate	-	-
Utilities	-	-

Return for Risk

HELX vs. PSCH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX

HELX Risk / Return Rank: 42
HELX Sharpe Ratio Rank: 47
HELX Sortino Ratio Rank: 48
HELX Omega Ratio Rank: 44
HELX Calmar Ratio Rank: 39
HELX Martin Ratio Rank: 33

PSCH

PSCH Risk / Return Rank: 20
PSCH Sharpe Ratio Rank: 19
PSCH Sortino Ratio Rank: 21
PSCH Omega Ratio Rank: 20
PSCH Calmar Ratio Rank: 20
PSCH Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HELX vs. PSCH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HELX	PSCH	Difference
Sharpe ratio: Return per unit of total volatility	1.61	0.64	+0.97
Sortino ratio: Return per unit of downside risk	2.32	1.06	+1.26
Omega ratio: Gain probability vs. loss probability	1.28	1.12	+0.15
Calmar ratio: Return relative to maximum drawdown	1.89	0.85	+1.03
Martin ratio: Return relative to average drawdown	4.88	2.36	+2.52
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HELX vs. PSCH - Sharpe Ratio Comparison

The current HELX Sharpe Ratio is 1.61, which is higher than the PSCH Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of HELX and PSCH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HELX	PSCH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	0.64	+0.97
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.16	-0.23	+0.07
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.30	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.52	-0.27

Drawdowns

HELX vs. PSCH - Drawdown Comparison

The maximum HELX drawdown since its inception was -58.75%, which is greater than PSCH's maximum drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for HELX and PSCH.

Drawdown Indicators

	HELX	PSCH	Difference
Max Drawdown Largest peak-to-trough decline	-58.75%	-46.32%	-12.43%
Max Drawdown (1Y) Largest decline over 1 year	-18.01%	-15.36%	-2.65%
Max Drawdown (3Y) Largest decline over 3 years	-29.48%	-22.98%	-6.50%
Max Drawdown (5Y) Largest decline over 5 years	-58.75%	-46.32%	-12.43%
Max Drawdown (10Y) Largest decline over 10 years	—	-46.32%	—
Current Drawdown Current decline from peak	-38.22%	-28.74%	-9.48%
Average Drawdown Average peak-to-trough decline	-34.32%	-13.46%	-20.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.95%	5.54%	+1.41%

Volatility

HELX vs. PSCH - Volatility Comparison

Franklin Genomic Advancements ETF (HELX) has a higher volatility of 7.45% compared to Invesco S&P SmallCap Health Care ETF (PSCH) at 4.97%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HELX	PSCH	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.45%	4.97%	+2.48%
Volatility (6M) Calculated over the trailing 6-month period	16.47%	14.30%	+2.17%
Volatility (1Y) Calculated over the trailing 1-year period	21.07%	20.38%	+0.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.15%	22.92%	+1.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.41%	23.64%	+3.77%

HELX vs. PSCH - Expense Ratio Comparison

HELX has a 0.50% expense ratio, which is higher than PSCH's 0.29% expense ratio.

Dividends

HELX vs. PSCH - Dividend Comparison

HELX's dividend yield for the trailing twelve months is around 0.40%, more than PSCH's 0.01% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
HELX Franklin Genomic Advancements ETF	0.40%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%	0.00%	0.00%	0.00%	0.00%
PSCH Invesco S&P SmallCap Health Care ETF	0.01%	0.04%	0.27%	0.01%	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%

Frequently Asked Questions

Can I hold both HELX and PSCH in my portfolio?

HELX and PSCH have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HELX or PSCH?

HELX has higher volatility (7.45%) compared to PSCH (4.97%). In terms of maximum drawdown, HELX dropped -58.75% vs PSCH's -46.32%.

Which ETF is better, HELX or PSCH?

On 5-year performance, HELX leads with -3.93% vs -5.22% for PSCH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.97%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, HELX or PSCH?

Over the 5-year period, HELX has performed better with a -3.93% return vs -5.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, HELX or PSCH?

PSCH is cheaper with a 0.29% expense ratio, compared with 0.50% for HELX.

Which ETF pays a higher dividend yield, HELX or PSCH?

HELX has the higher dividend yield at 0.40%, compared with 0.01% for PSCH.

What is the main difference between HELX and PSCH?

They also come from different issuers: Franklin Templeton and Invesco. Their fees differ too: 0.50% for HELX and 0.29% for PSCH.

Which has better risk-adjusted returns?

HELX currently has the higher Sharpe Ratio (1.61 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.